Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Jean Bernadou"'
Autor:
Guillaume Poiroux, Marguerite Pitié, Raphaël Culerrier, Elodie Lafont, Bruno Ségui, Els J M Van Damme, Willy J Peumans, Jean Bernadou, Thierry Levade, Pierre Rougé, Annick Barre, Hervé Benoist
Publikováno v:
PLoS ONE, Vol 6, Iss 8, p e23315 (2011)
Photochemotherapy is used both for solid tumors and in extracorporeal treatment of various hematologic disorders. Nevertheless, its development in oncology remains limited, because of the low selectivity of photosensitizers (PS) towards human tumor c
Externí odkaz:
https://doaj.org/article/a8620ab1c7fd4b5fb175c50679e15cb8
Autor:
Jean-Luc Stigliani, Vania Bernardes-Génisson, Maria Rosalia Pasca, Geneviève Pratviel, Giorgia Mori, Jean Bernadou, Annaïk Quémard, Christian Lherbet, Patricia Constant, Aurélien Chollet
Publikováno v:
Chemical Biology and Drug Design
Chemical Biology and Drug Design, Wiley, 2016, 88 (5), pp.740-755. ⟨10.1111/cbdd.12804⟩
Chemical Biology and Drug Design, 2016, 88 (5), pp.740-755. ⟨10.1111/cbdd.12804⟩
Chemical Biology and Drug Design, Wiley, 2016, 88 (5), pp.740-755. ⟨10.1111/cbdd.12804⟩
Chemical Biology and Drug Design, 2016, 88 (5), pp.740-755. ⟨10.1111/cbdd.12804⟩
International audience; Inhibitors of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA) are considered as potential promising therapeutics for the treatment of tuberculosis. Previously, we reported that azaisoindolinone-type compounds display
Autor:
Patricia Constant, Jean Bernadou, Frédéric Coslédan, Bernard Meunier, Tamara Delaine, Annaïk Quémard, Vania Bernardes-Génisson
Publikováno v:
Chemical Biology & Drug Design. 79:1001-1006
Five lipophilic analogues 1–5 of the active metabolite of the antitubercular drug isoniazid (INH), selected as inhibitors of Mycobacterium smegmatis and Mycobacterium tuberculosis growth, were evaluated for their activity against Corynebacterium gl
Autor:
Thierry Levade, Hervé Benoist, Bruno Ségui, Raphaël Culerrier, Marguerite Pitié, Pierre Rougé, Guillaume Poiroux, Willy J. Peumans, Els J.M. Van Damme, Jean Bernadou, Annick Barre
Publikováno v:
Photochemistry and Photobiology. 87:370-377
Porphyrins are used as photosensitizer (PS) in photodynamic therapy in cancer treatment. Nevertheless, the development of photochemotherapy in oncology remains limited, because of the low selectivity of PSs. In order to allow PS targeting toward tumo
Autor:
Jean Bernadou, Vania Bernardes-Génisson, Jean-Luc Stigliani, Tamara Delaine, Philippe Arnaud, Bernard Meunier
Publikováno v:
Journal of Molecular Graphics and Modelling. 27:536-545
The front-line antituberculosis drug isoniazid (INH) inhibits InhA, the NADH-dependent fatty acid biosynthesis enoyl ACP-reductase from Mycobacterium tuberculosis, via formation of covalent adducts with NAD (INH-NAD adducts). While ring tautomers wer
Autor:
Jean-Luc Stigliani, Vania Bernardes-Génisson, Bernard Meunier, Jean Bernadou, Heinz Gornitzka, Tamara Delaine
Publikováno v:
European Journal of Organic Chemistry. 2007:1624-1630
Simplified analogues of oxidized and reduced isoniazid–NAD(P) adducts were prepared to study their behaviour with regard to ring–chain tautomeric isomerism in solution. In DMSO, the oxidized analogues (pyridinium salts) and the corresponding 1,2-
Autor:
Alexandra Delbot, Michel Baltas, Aurélien Chollet, Sylviane Julien, Christian Lherbet, Lionel Mourey, Geneviève Pratviel, Laurent Maveyraud, Vania Bernardes-Génisson, Jean Bernadou
Publikováno v:
Journal of Structural Biology
Journal of Structural Biology, Elsevier, 2015, 190, pp.328-337. ⟨10.1016/j.jsb.2015.04.008⟩
Journal of Structural Biology, 2015, 190, pp.328-337. ⟨10.1016/j.jsb.2015.04.008⟩
Journal of Structural Biology, Elsevier, 2015, 190 (3), pp.328-337. ⟨10.1016/j.jsb.2015.04.008⟩
Journal of Structural Biology, Elsevier, 2015, 190, pp.328-337. ⟨10.1016/j.jsb.2015.04.008⟩
Journal of Structural Biology, 2015, 190, pp.328-337. ⟨10.1016/j.jsb.2015.04.008⟩
Journal of Structural Biology, Elsevier, 2015, 190 (3), pp.328-337. ⟨10.1016/j.jsb.2015.04.008⟩
International audience; InhA is an enoyl-ACP reductase of Mycobacterium tuberculosis implicated in the biosynthesis of mycolic acids, essential constituents of the mycobacterial cell wall. To date, this enzyme is considered as a promising target for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ec7155ebdea6aae0da28680023e2d89
https://hal.archives-ouvertes.fr/hal-03002973/file/chollet-jstructbiol15.pdf
https://hal.archives-ouvertes.fr/hal-03002973/file/chollet-jstructbiol15.pdf
Autor:
Jean Bernadou, Bernard Meunier
Publikováno v:
Advanced Synthesis & Catalysis. 346:171-184
An overview of the biomimetic catalysts used in the oxidative activation of drugs is given, with an emphasis on the use of synthetic metalloporphyrins as models of cytochrome P450 to mimic the in vivo metabolism of pharmaceuticals. In addition, a spe
Autor:
Hedia Marrakchi, Annaíik Quémard, Stéphanie Ducasse-Cabanot, Mamadou Daffé, Gilles Labesse, Jean Bernadou, Martin Cohen-Gonsaud, Michel Nguyen, Didier Zerbib
Publikováno v:
Antimicrobial Agents and Chemotherapy. 48:242-249
The first-line specific antituberculous drug isoniazid inhibits the fatty acid elongation system (FAS) FAS-II involved in the biosynthesis of mycolic acids, which are major lipids of the mycobacterial envelope. The MabA protein that catalyzes the sec
Publikováno v:
Chemistry - A European Journal. 9:2034-2038
Isoniazid (INH) is easily oxidized with manganese(III) pyrophosphate, a chemical model of the KatG protein involved in activation of INH inside the bacteria Mycobacterium tuberculosis. Performed in the presence of NAD(+), this oxidation generates a f